<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on PamGene International B.V. from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated PamGene International B.V. news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 14:31:58 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=PamGene+International+B.V." rel="self" type="application/rss+xml" />

	
<item><title>Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041794&amp;HITNO=0&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041794&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539226410%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041794&amp;HITNO=0&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041794&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539226410%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042471&amp;HITNO=1&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042471&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539430490%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042471&amp;HITNO=1&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042471&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539430490%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Francisco Business Times:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042470&amp;HITNO=2&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042470&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539430324%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042470&amp;HITNO=2&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042470&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539430324%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Portland Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042391&amp;HITNO=3&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042391&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539412030%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042391&amp;HITNO=3&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042391&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539412030%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sacramento Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042371&amp;HITNO=4&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042371&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539406829%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042371&amp;HITNO=4&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042371&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539406829%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Twin Cities Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042198&amp;HITNO=5&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042198&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539352363%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4042198&amp;HITNO=5&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4042198&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539352363%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041920&amp;HITNO=6&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041920&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539256036%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041920&amp;HITNO=6&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041920&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539256036%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Houston Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041774&amp;HITNO=7&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041774&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539223715%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041774&amp;HITNO=7&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041774&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539223715%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Charlotte Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041770&amp;HITNO=8&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041770&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539223408%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041770&amp;HITNO=8&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041770&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539223408%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Baltimore Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041754&amp;HITNO=9&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041754&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539221250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041754&amp;HITNO=9&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041754&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539221250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Kansas City Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041685&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041685&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539204871%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041685&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041685&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539204871%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041663&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041663&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539198735%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041663&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041663&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539198735%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Triad Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Amer</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041639&amp;HITNO=12&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041639&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539191040%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041639&amp;HITNO=12&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041639&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539191040%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TickerTech.com:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041631&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041631&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539189019%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041631&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041631&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539189019%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Jose Business Journal:</description></item>
<item><title>Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041583&amp;HITNO=14&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041583&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539174464%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4041583&amp;HITNO=14&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=PamGene%20International%20B.V.&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4041583&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2539174464%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
</channel></rss>